• In long-term analyses of 2 clinical trials that included patients with chronic kidney disease, a lower blood pressure target than the currently guideline-recommended goal of 140/90 mm Hg was safe and associated with protection against premature death
The risk of sports fans catching dengue fever during the Rio Olympics is very low, according to a new study involving mathematicians at the University of Strathclyde.
Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to stopping the bleeding as quickly as possible. Many methods for controlling external bleeding exist, but at this point, only surgery can halt blood loss inside the body from injury to internal organs. Now, researchers have developed nanoparticles that congregate wherever injury occurs in the body to help it form blood clots, and they’ve validated these particles in test tubes and in vivo.
The new testing method is a significant improvement for patients because it utilizes a simple blood sample, eliminating the need for a much more invasive lung biopsy that was previously required to test for the genetic mutation.
Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood clotting over the long-term, even when patients have been historically stable on the drug, according to a study from the Duke Clinical Research Institute.
On January 24, 2013, Iris Vega-Figueroa’s life changed completely.That’s the day she gave birth to her twin girls, Iris and Geraldine.
Eliminating racial disparities in the outcomes of programs to control blood pressure can be accomplished with a few one-on-one coaching sessions delivered by health professionals —but not if the program requires people to get to a clinic, according to results of a new Johns Hopkins Medicine study. The finding, described in the current issue of the Ethnicity & Disease journal, adds to mounting evidence that health and wellness programs work best when medical practitioners go out to people in their communities.
Ortho Clinical Diagnostics will present seven scientific posters on its assays and display six products at the 2016 American Association for Clinical Chemistry (AACC) annual meeting. Ortho’s posters will address a range of important tests, both marketed and in-development for clinical labs.
New research by University of Iowa scientists helps explain how a hormone system often targeted to treat cardiovascular disease can also lower metabolism and promote obesity.
Australian researchers have made a world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia.
Research into Africa's first 'screen-and-treat' programme for hepatitis B suggests the initiative may reduce deadly complications of the virus.
A University of Colorado Cancer Center study finds that three years post bone marrow transplant, the incidence of severe chronic graft-versus-host disease was 44 percent in patients who had received transplants from matched, unrelated donors (MUD) and 8 percent in patients who had received umbilical cord blood transplants (CBT).
Personalized Medicine Leads to Better Outcomes; Phase 1 Study Results of Selinexor Combination Therapy for Multiple Myeloma Patients; and the Latest from ASCO Sessions in the Cancer News Source
University of Washington researchers have developed the first simulator for duplex ultrasound scanning, a type of ultrasound used to assess the health of blood vessels.
Hematology researchers have developed a novel genetically engineered clotting factor that can control bleeding in animal models. If the factor proves effective and safe in humans, it may provide a quick-acting countermeasure for surgery patients and others vulnerable to serious bleeding as a result of new blood-thinning drugs.
Click here to go directly to the Cardiovascular Health News Source
Advanced Instruments, Inc., a leader in laboratory instrumentation, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its GloCyte Automated Cell Counter System and GloCyte Low and High Level Controls.
Researchers from the University of Birmingham and hospitals across the West Midlands have revealed how a common symptomless condition can develop into the blood cancer myeloma.
An article published on July 6, 2016 in The Lancet ranks viral hepatitis infections – specifically both Hepatitis B (HBV) and Hepatitis C (HCV) – as the seventh leading cause of death worldwide in 2013, up from tenth in 1990. …hepatitis C is a critical public health concern that, despite the consistent release of research stating its increasing adverse impact on public health, continues to see woeful underfunding for prevention and treatment initiatives to curtail its spread.
For patients treated in a hospital, the risk of death from acute myeloid leukemia was elevated in three regions of North Carolina compared to a benchmark.
Recent studies on a small number of patients with leukemia treated with bone marrow transplantation have suggested that the presence of the common cytomegalovirus (CMV) in patients or their donors may protect against relapse or even death after the transplant. A large international study published in the journal Blood now shows the opposite. The virus not only does not prevent leukemia relapse, but also remains a major factor associated with the risk of death.
Vasculitis Foundation's "VF Team Brandon" supports Olympic hopeful's dream
Multicenter, phase II trial suggests autologous transplant should be standard of care for HIV patients with relapsed/treatment-resistant lymphoma.
Midwest Orthopaedics at Rush physicians find arthroscopic surgery to be effective, especially in those under 45.
Johns Hopkins Medicine researchers report that rising blood levels of a protein called hematoma derived growth factor (HDGF) are linked to the increasing severity of pulmonary arterial hypertension, a form of damaging high blood pressure in the lungs.
In a surprising twist, benign brain tumors that have previously been tied to obesity and diabetes are less likely to emerge in those with high blood sugar, new research has found.
A study published in the New England Journal of Medicine on May 26 showed that participants who received a recombinant therapy— the present standard in the United States — developed antibodies or “inhibitors” to the treatments at almost twice the rate as those whose treatments were made from human plasma.
Incorrectly folded proteins can cause a variety of diseases. Danish researchers have found a solution for preventing this misfolding.
Blacks are four times more likely than their white counterparts to die from stroke at age 45.
UCSF researchers that it is possible to generate healthy new liver cells in the livers of living mice by converting the very cells that drive liver disease, thereby reducing liver damage and improving liver function at the same time.
Johns Hopkins scientists who indirectly investigated the blood sugar effects of 10 (out of 32 selected) commercial weight loss programs say a few show promise of benefit for diabetic patients, but far more rigorous research is needed before doctors can wholeheartedly recommend them.
African study finds genes that double the chance of developing bacteraemia when infected with the Streptococcus pneumoniae bacteria.
Dylan Martin wasn’t sure he’d ever be able to graduate from college, but his concern stemmed from something far more serious than how he was doing in his classes.
Red blood cell exchange offers the risk lowering benefit of frequent blood transfusions but does so without increasing the iron stored in the body. Patients are connected to an apheresis machine which removes sickled red cells and replaces them with normal red cells from donors.
In addition the technique to grow the blood vessels in a 3D scaffold cuts down on the risk of transplant rejection because it uses cells from the patient. It was developed by researchers from the University of Bath's Department of Pharmacy and Pharmacology, working with colleagues at Bristol Heart Institute.
For the eighth year in a row, Loyola University Medical Center has received the American Heart Association/American Stroke Association’s Get With the Guidelines®-Stroke Gold Plus Quality Achievement Award.
Mariana was brought to Loyola Medical Center to treat a rare brain tumor at the young age of five. Her treatment process was extensive, including surgery, radiation and intense chemotherapy. Throughout it all, Mariana kept an optimistic attitude.
UT Southwestern Medical Center has joined an international consortium of leading universities to study the effectiveness of various stroke treatments from the patient’s perspective.
Doctors change practice trends as debate continues on optimal time to administer antiplatelet therapy.
A laboratory blood test developed at Johns Hopkins for the diagnosis of a rare genetic red blood cell disorder also shows promise in identifying HELLP syndrome, a life-threatening high blood pressure condition affecting 1 percent of all pregnant women.
click to view today's top stories
click to view today's top stories
A study from Columbia University Medical Center found that lowering blood pressure goals for people with cardiovascular risk factors could save tens of thousands of lives annually and reduce costs.
click to see today's top stories
click to see today's top stories
Diagnosing Mononucleosis, Need for Health Interventions for Single Parent Households in Urban Subsidized Housing Programs, Inadequate Financial Savings Tied to Increased Childhood Health Risks, and more in the Public Health News Source
Synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases: beta-thalassemia and polycythemia vera. The compounds restored red blood cell levels of red blood cells and controlled iron absorption in animal models.
University of Vermont blood-clotting expert Mary Cushman, M.D., M.Sc., talks about the reasons why sometimes fatal blood clots occur in elite athletes like the Portland Trail Blazers' Jerome Kersey, tennis great Serena Williams and most recently, the Miami Heat's Chris Bosh.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right